Getting both shots of two-dose COVID vaccines is important and 92% of Americans have, better than similar vaccines. For the 8%, It’s not too late.
Author: Elizabeth Weise, USA TODAY
COVID toes, Moderna arm, all-body rash: Vaccines can cause skin reactions but aren’t dangerous, study says
A new study finds some COVID-19 vaccine skin reactions, including a measles-like rash and shingles, are rare, and thankfully brief, side effects.
COVID toes, Moderna arm, all-body rash: Vaccines can cause skin reactions but aren’t dangerous, study says
A new study finds some COVID-19 vaccine skin reactions, including a measles-like rash and shingles, are rare, and thankfully brief, side effects.
COVID toes, Moderna arm, all-body rash: Vaccines can cause skin reactions but aren’t dangerous, study says
A new study finds some COVID-19 vaccine skin reactions, including a measles-like rash and shingles, are rare, and thankfully brief, side effects.
What if you had your choice of COVID-19 vaccine? Differences are small, but they do exist
If you get the choice, which COVID-19 vaccine should you choose? For now, any one you can get. But supply is growing, and there are differences.
Three vaccines. Increased manufacturing. How US will have enough COVID-19 vaccine for every US adult in May – or even sooner.
President Joe Biden says there will be enough COVID-19 vaccine available in May for every U.S. adult. Some experts say it could even be sooner.
Want to hug again? Go to church? ‘It’s up to you,’ Ad Council says in $500M campaign to promote COVID-19 vaccines
The ads are aimed at the 40% of Americans who haven’t yet made up their minds about getting vaccinated against COVID-19.
‘Somewhere in there, the vaccine got overpromised’: How the COVID-19 vaccination process turned chaotic and confusing
A lack of transparency, coupled with a short supply, has complicated America’s COVID-19 vaccination efforts. Are things getting better now?
There’s not a ‘giant national campaign’ for COVID-19 vaccine education. Why? Experts say there’s a better way.
Communication experts say targeted messaging is the right approach to address COVID-19 vaccine hesitancy and raise awareness of public health efforts.
‘This is fantastic’: Mass vaccination clinics to play key role in ending COVID-19 pandemic
High-volume vaccination centers will become common in US as the Biden administration seeks to vaccinate 1.5 million a day.